BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.73% |
| 2 | Financials | 5.47% |
| 3 | Healthcare | 4.96% |
| 4 | Consumer Discretionary | 4.64% |
| 5 | Industrials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Interface
TILE
$2.23B
| $312K | ﹤0.01% |
18,826
+7,084
| +60% | +$114K |
|
|
WPG
2627
DELISTED
Washington Prime Group Inc.
WPG
| $312K | ﹤0.01% |
9,523
+5,749
| +152% | +$209K |
|
|
HIBB
2628
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $312K | ﹤0.01% |
11,118
-3,343
| -23% | -$84.8K |
|
|
MAGN
2629
Magnera Corp
MAGN
$443M
| $311K | ﹤0.01% |
1,309
+699
| +115% | +$155K |
|
2630
Cohen & Steers
CNS
$4.36B
| $311K | ﹤0.01% |
4,957
-466
| -9% | -$29.5K |
|
|
MNR
2631
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $310K | ﹤0.01% |
21,413
+7,117
| +50% | +$105K |
|
2632
Kelly Services Class A
KELYA
$536M
| $310K | ﹤0.01% |
13,729
+7,948
| +137% | +$179K |
|
2633
Inogen
INGN
$154M
| $310K | ﹤0.01% |
4,533
+1,228
| +37% | +$77K |
|
2634
Eldorado Gold
EGO
$10.4B
| $309K | ﹤0.01% |
38,445
+5,262
| +16% | +$40.8K |
|
2635
iShares MSCI Taiwan ETF
EWT
$11.6B
| $309K | ﹤0.01% |
7,502
-1,653
| -18% | -$65.1K |
|
|
TRST
2636
Trustco Bank Corp NY
TRST
$963M
| $307K | ﹤0.01% |
7,093
+4,102
| +137% | +$176K |
|
|
AQUA
2637
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $307K | ﹤0.01% |
16,188
+2,125
| +15% | +$38.1K |
|
2638
ArcelorMittal
MT
$55.9B
| $306K | ﹤0.01% |
17,438
-4,264
| -20% | -$69.1K |
|
2639
Red Rock Resorts
RRR
$3.73B
| $305K | ﹤0.01% |
12,750
+109
| +0.9% | +$2.42K |
|
2640
Corcept Therapeutics
CORT
$12.1B
| $304K | ﹤0.01% |
25,162
+7,533
| +43% | +$105K |
|
2641
Insmed
INSM
$28.9B
| $304K | ﹤0.01% |
12,739
-2,993
| -19% | -$60.9K |
|
2642
BOK Financial
BOKF
$8.85B
| $304K | ﹤0.01% |
3,475
-1,000
| -22% | -$81.5K |
|
2643
SITE Centers
SITC
$156M
| $304K | ﹤0.01% |
27,763
-77,519
| -74% | -$883K |
|
2644
Ares Capital
ARCC
$14.3B
| $304K | ﹤0.01% |
16,280
+9,904
| +155% | +$184K |
|
2645
Toronto Dominion Bank
TD
$204B
| $303K | ﹤0.01% |
5,400
| – | – |
|
2646
Freshpet
FRPT
$3.48B
| $303K | ﹤0.01% |
5,126
-300
| -6% | -$16K |
|
2647
The RealReal
REAL
$1.36B
| $303K | ﹤0.01% |
16,059
+13,453
| +516% | +$258K |
|
2648
DigitalBridge
DBRG
$2.95B
| $302K | ﹤0.01% |
15,869
-31,437
| -66% | -$648K |
|
|
CBPX
2649
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $301K | ﹤0.01% |
8,256
+1,648
| +25% | +$54.2K |
|
2650
Usana Health Sciences
USNA
$250M
| $300K | ﹤0.01% |
3,819
+1,522
| +66% | +$112K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.